Linked Life Data

18328660

Source:http://linkedlifedata.com/resource/pubmed/id/18328660

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-6-9
pubmed:abstractText
Posttreatment imaging is done when a recurrent tumour is suspected, to confirm the presence of such a lesion and to determine its extent. The extent of a recurrent cancer is important information for determining the possibility of salvage therapy. Imaging may also be used to monitor tumour response and to try to detect recurrent or persistent disease before it becomes clinically evident, possibly with a better chance for successful salvage. This article reviews the expected imaging findings after treatment of head and neck squamous cell cancer, and how to differentiate these from persistent or recurrent cancer. The relative value of anatomical and biological imaging modalities, including newer techniques such as diffusion-weighted magnetic resonance imaging, is addressed. The imaging findings in treatment-induced complications, such as tissue necrosis, sometimes difficult to differentiate from cancer, are explained.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0720-048X
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
501-11
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Posttreatment imaging in head and neck cancer.
pubmed:affiliation
Department of Radiology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Robert.Hermans@uzleuven.be
pubmed:publicationType
Journal Article, Review